Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 37Observational 2

Sponsor

Cancer Type

Other solid neoplasm 4Thoracic 3Breast 3Gastrointestinal 2CNS 2Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Liver Cirrhosis 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 80Surgical Procedures, Operative 53Observation 44Drug Therapy 44Colonoscopy 41Bevacizumab 41Biopsy 35Hepatectomy 33Capecitabine 27Neoadjuvant Therapy 26Immune Checkpoint Inhibitors 26regorafenib 25Interviews as Topic 25Radiotherapy 24Oxaliplatin 24Sorafenib 22Magnetic Resonance Spectroscopy 22lenvatinib 21Endoscopic Mucosal Resection 21Specimen Handling 18Immunohistochemistry 18Endoscopy 18Pancreaticoduodenectomy 17Liquid Biopsy 17Gastrectomy 17Endoscopic Ultrasound-Guided Fine Needle Aspiration 17Tomography, X-Ray Computed 16Gastroscopy 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Fluorodeoxyglucose F18 × Gastrointestinal × Clear all
NCT02899325 2023-02-21

FDGal PET/CT to Detect Hepatocellular Carcinoma

British Columbia Cancer Agency

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

NCT00550628 2015-12-23

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Memorial Sloan Kettering Cancer Center

Completed
8 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡